Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 1,944 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Primary Progressive Aphasia
Interventions: Remotely supervised Transcranial Direct Current Stimulation (RS-tDCS), Remotely supervised sham tDCS (RS-sham-tDCS), Lexical Retrieval Training (LRT), Video Implemented Script Training in Aphasia (VISTA); Device · Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: San Francisco, California • Austin, Texas

Conditions: Compliance With Terms of Probation Sentence
Interventions: Motivational Interviewing; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas, Adenosquamous Carcinoma of the Pancreas
Interventions: ZIMBERELIMAB, DOMVANALIMAB, APX005M, FOLFIRI; Drug
Lead sponsor: James Cleary, MD, PhD; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obstructive Sleep Apnea
Interventions: Low flow oxygen via nasal cannula, Humidified Nasal High Flow Therapy; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Early Breast Cancer
Interventions: PF-05280014, Taxotere®, Paraplatin®, Trastuzumab-EU; Biological · Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 4
States / cities: Fountain Valley, California • Kingwood, Texas • Shenandoah, Texas

Conditions: Obesity, Overweight, Pregnancy Related
Interventions: Antenatal Obesity Treatment (AO); Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 416 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Alcohol Dependence
Interventions: CI-581a, CI-581b, Motivational Enhancement Therapy (MET); Drug · Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 21 Years to 69 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Interventions: FATE-NK100, Interleukin-2; Biological · Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: HIV, Alcoholism
Interventions: Provider Training, Patient Intervention; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Birmingham, Alabama • Baltimore, Maryland • Seattle, Washington

Conditions: Inactivity, Inactivity/Low Levels of Exercise, Inactivity, Physical
Interventions: Remote Physical Activity Intervention, Mindfulness Enhanced Remote Physical Activity Intervention, Attention Matched Enhanced Remote PA intervention; Behavioral
Lead sponsor: Bess Marcus; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 258 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: High-risk Muscle Invasive Urothelial Carcinoma
Interventions: Dato-DXd, Rilvegostomig, Durvalumab, Nivolumab, Pembrolizumab, Enfortumab vedotin; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 915 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 19
States / cities: Hot Springs, Arkansas • Little Rock, Arkansas • San Francisco, California + 15 more

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: Mobile and connected health; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Houston, Texas

Conditions: Food Allergy
Interventions: Omalizumab; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 1 Year to 30 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Medication Administered in Error, Antipsychotics and Neuroleptics Toxicity
Interventions: Simulation, Online educational training; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anxiety Disorders, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia, Major Depressive Disorder, Persistent Depressive Disorder (Dysthymia)
Interventions: Mindful Self-Compassion; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Infection
Interventions: Antimicrobial Solution; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypertension
Interventions: Health Literacy-Focused High Blood Pressure Intervention; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 60 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Ellicott City, Maryland

Conditions: Lipedema
Interventions: Intermittent pneumatic compression therapy; Device
Lead sponsor: Lympha Press; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stage IV Gastrointestinal Cancer, Advanced Gynecological Cancer
Interventions: Stop, Breathe & Think™, End of Life Planning Videos, Caregiver wellness videos; Behavioral
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity
Interventions: Food, Fun, & Fitness Internet Program for Girls; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 8 Years to 10 Years · Female only
Enrollment: 342 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Language Development Disorders
Interventions: Language Intervention; Behavioral
Lead sponsor: Karla McGregor; Other
Eligibility: 4 Years to 7 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Type 2 Diabetes Mellitus
Interventions: V-Go™; Device
Lead sponsor: Valeritas, Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 25
States / cities: Chula Vista, California • San Francisco, California • Danbury, Connecticut + 20 more

Conditions: Knee Injury
Interventions: NMES, Strength Walking, Standard Rehabilitation Protocol; Device · Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years to 50 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Andrews Air Force Base, Maryland • Bethesda, Maryland

Conditions: Hypertension
Interventions: Level of noise and environment (public vs private) while taking blood pressure measurement; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Speech-Language Treatment With Remotely Supervised Transcranial Direct Current Stimulation in Primary Progressive Aphasia

An Evaluation of Motivational Interviewing to Increase Compliance in a Probation Setting

Switch Maintenance in Pancreatic

Postoperative Nasal High Flow Versus Oxygen for Positive Airway Pressure Non-Compliance Sleep Apnea Patients

A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)

Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy

Glutamatergic Modulation of Disordered Alcohol Use

Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int

ARCH Research Protocol for Provider Alcohol Pharmacotherapy Training and Assessment

Improving Physical Activity Participation in Latinas With Mindfulness

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Connecting Smartphones With Electronic Health Record to Facilitate Behavioral Goal Monitoring in Diabetes Care

Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy

Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing

Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method

Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)

Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans

Effects of Intermittent Pneumatic Compression Therapy on Tissue Volume, Pain, and Quality of Life in Lipedema

The Mediating Effects of Decentering on Self-Management of Stress and End of Life Planning

Food, Fun, & Fitness Internet Program for Girls: Outcome Evaluation

Improving STEM Outcomes for Young Children With Language Learning Disabilities Via Telehealth

Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting

Electromyostimulation and Strength Walking for Knee Injuries

Determining Change In Blood Pressure Due to Environment and Loudness